[1]
“A STUDY OF THE POSSIBLE DRUG-DRUG INTERACTIONS INVOLVING ORAL ANTIDIABETIC DRUGS IN PATIENTS WITH TYPE II DIABETES ”, Int. Res. J. Pharm., vol. 10, no. 5, pp. 141–144, May 2019, Accessed: Jul. 17, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/486